AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, smarter path to launch.
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #9 is a biotech by the name of Immunic (IMUX). The reason why I believe that it is important to go over ...
A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like science fiction a decade ago. Instead of scanning DNA for one mutation at a ...
We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Black Diamond Therapeutics, Inc. is one of the twenty best biotech stocks. TheFly reported on January 16 that Piper ...
After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...
INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Atelerix, a biotech company working on cell preservation and biological transport with its hydrogel encapsulation technology, entered a partnership with Cherry Biotech, a French company specializing ...